Product was Humacyte’s largest product and service line in fiscal 2025, bringing in $4.17M of $6.11M (68%).
| Product and Service | FY 2025 |
|---|---|
| Product | $4.17M |
| Contract Revenue | $1.95M |
| Total | $6.11M |
Humacyte brought in $6.11M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. Product was the largest at $4.17M (68.2%), ahead of Contract Revenue at $1.95M (31.8%).
Humacyte (HUMA) reports its revenue by product and service. In fiscal 2025, Product was its largest product and service line, bringing in $4.17M (68.2% of the total), followed by Contract Revenue at $1.95M (31.8%).
Product was Humacyte's largest product and service line in fiscal 2025, bringing in $4.17M, or 68.2% of the $6.11M total across its two product and service lines.
Every figure comes from Humacyte's annual financial filings, as reported. Each line keeps the name Humacyte gives it, and years follow its fiscal calendar.
Humacyte's revenue by product and service goes back to fiscal 2025, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.